Krsnaa Diagnostics CFO Pawan Daga Resigns; Last Day Jan 19, 2026
Mr. Pawan Daga, Chief Financial Officer of Krsnaa Diagnostics Limited, has resigned. His last working day will be January 19, 2026. The company cited personal and professional priorities as the reason for his departure and acknowledged his five-year tenure.
The resignation of a CFO can have a medium-term impact on the company's financial strategy and investor confidence until a suitable replacement is found.
The resignation of a key managerial personnel is a significant event, but the company has acknowledged his contributions and the reason provided is standard. The impact is neutral as no immediate financial or operational disruption is indicated.
Krsnaa Diagnostics Limited announced that Mr. Pawan Daga, the Chief Financial Officer (CFO) of the company, has submitted his resignation.
Mr. Daga's last day of employment with Krsnaa Diagnostics will be January 19, 2026, at the close of business hours. The company expressed its sincere appreciation for his five years of service and his contributions to the company's growth.
The reason cited for his resignation is personal and professional priorities. Mr. Daga is classified as Key Managerial Personnel, and the company has provided the necessary disclosures as per SEBI regulations.
What to do with a filing like this
Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.